England

In October 2025, the National Institute for Health and Care Research (NIHR) in England released four Med Tech-related assessments in its HTA Journal, which concerned tumor profiling tests in early breast cancer, remote monitoring of heart failure in people with cardiac implantable electronic devices, microstructural scaffolds in symptomatic defects of the knee, as well as rapid tests for antifungal stewardship in the ICU.

In October 2025, the National Institute for Health and Care Excellence (NICE) published one new Early Value Assessment on AI technologies for the detection of vertebral fragility fractures and two new Interventional Procedures Guidances on venoarterial extracorporeal membrane oxygenation (VA-ECMO) in refractory cardiac arrest and severe acute heart failure.

In September 2025, the National Institute for Health and Care Research (NIHR) in England released four Med Tech-related assessments in its HTA Journal, which concerned pulmonology, in-vitro diagnostics, cardiology, and dermatology fields.

On August 19, 2025, NHS England announced that most integrated care boards (ICBs, local commissioners) will coordinate their work by gathering in clusters. Thirteen clusters, each comprising two to three ICBs, will be established by the end of 2025, while thirteen ICBs will continue to operate independently.

On September 1, 2025, the application window opened to join the 2026 NHS Innovation Accelerator (NIA) program. NIA supports the development of innovators (Fellows) and the spread of their innovation nationally. The 2026 call is not limited to a specific theme and is open to innovations addressing any health and care challenges. The application deadline is October 12, 2025.

In August 2025, the National Institute for Health and Care Research (NIHR) in England released three Med Tech-related assessments in its HTA Journal, which concerned nephrology and urology, endocrinology, radiotherapy, and neurosurgery fields.

On August 21, 2025, NHS England published an updated work plan for the development of Clinical Commissioning Policies for specialised services. One new MedTech-related policy concerning renal denervation for resistant hypertension was added to the work program, and none have been published since the previous update. The status of ongoing policies has also been updated.

In August 2025, the National Institute for Health and Care Excellence (NICE) published three new Late Stage Assessments on transcatheter heart valves for TAVI, bed frames in acute medical or surgical hospital wards, and compression products for venous leg ulcers.

In August 2025, the National Institute for Health and Care Excellence (NICE) announced two new projects within its Health Technology Assessment Innovation Laboratory (HTA Lab). The projects explore generative AI technologies in economic modelling and how AI can support and enhance NICE’s HTA processes through automation, predictive modeling, and reasoning systems.

On August 7, 2025, the UK National Screening Committee (UK NSC) launched a public consultation on its proposed recommendation to continue the in-service evaluation of newborn screening for severe combined immunodeficiency (SCID) in real-world NHS settings. Stakeholders are invited to submit comments by October 27, 2025.

In July 2025, the National Institute for Health and Care Research (NIHR) in England released seven Med Tech-related assessments in its HTA Journal, which concerned nephrology and urology, pulmonology, gynecology, in-vitro diagnostics and e-Health fields.

In July 2025, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedures Guidance on pulsed-field ablation in atrial fibrillation, one new Early Value Assessment on digital technologies in anxiety and depression, and two new Late Stage Assessments (One-piece closed bags for colostomies, intermittent urethral catheters for chronic incomplete bladder emptying).